Blackstone Life Sciences V (Lux) SCSp — Form D
Blackstone Life Sciences V (Lux) SCSp of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-01-09. The offering totals $4.6B, of which $3.4B was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-01-09
- Form: D
- Accession: 0001797872-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $4.6B
- Amount sold: $3.4B
- Remaining: $1.1B
- Investors: 8
- Date of first sale: 2019-12-31
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-357600
Issuer
- Name: Blackstone Life Sciences V (Lux) SCSp
- CIK: 0001797872
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2019
- Address: 345 PARK AVENUE, NEW YORK, NY, 10154
- Phone: 212-583-5000
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Matthew G Skurbe | Executive Officer | New York, NY |
| N/A NA Blackstone Life Sciences Associates V (Lux) S.? r.l. | Promoter | New York, NY |
| Christopher G Placca | Executive Officer | New York, NY |
| Joseph G Baratta | Executive Officer | New York, NY |
| Robert G Liptak | Executive Officer | New York, NY |
| n/a na BXLS V L.L.C. | Promoter | New York, NY |
| Christopher G Striano | Executive Officer | New York, NY |
| Omar G Rehman | Executive Officer | New York, NY |
| John G Finley | Executive Officer | New York, NY |
| N/A NA Blackstone Life Sciences Associates V L.P. | Promoter | New York, NY |
| Nick G Galakatos | Executive Officer | New York, NY |
| N/A NA Blackstone Life Sciences Associates V (Lux) S.a r.l. | Promoter | New York, NY |
Other filings by this issuer (1)
More